Sogulasvhili, T. et al. 2026. Colchicine Plus Rosuvastatin/Ezetimibe for Residual Cardiovascular Risk: Mechanistic Rationale, Safety Concerns and Research Priorities. Georgian Biomedical and Medical Nexus. 4, 3 (Jul. 2026), 177–186. DOI:https://doi.org/10.52340/GBMN.2026.01.01.180.